
The study used molecular docking and pharmacokinetic analyses to evaluate their absorption, toxicity, and therapeutic potential. Results indicated L-arginine and citrulline have low toxicity and high absorption, making them strong candidates for future ED therapies. Resveratrol showed promising docking results but requires further toxicity assessment, emphasizing the need for deeper research to optimize their clinical application.
Like
Save
Share